Reviews - 1owt mentioned but not cited (4)
- The amyloid-beta precursor protein: integrating structure with biological function. Reinhard C, Hébert SS, Hébert SS, De Strooper B. EMBO J 24 3996-4006 (2005)
- Copper binding to the Alzheimer's disease amyloid precursor protein. Kong GK, Miles LA, Crespi GA, Morton CJ, Ng HL, Barnham KJ, McKinstry WJ, Cappai R, Parker MW. Eur Biophys J 37 269-279 (2008)
- Alzheimer's disease--a panorama glimpse. Zhao LN, Lu L, Chew LY, Mu Y. Int J Mol Sci 15 12631-12650 (2014)
- Disorder and cysteines in proteins: A design for orchestration of conformational see-saw and modulatory functions. Bhopatkar AA, Uversky VN, Rangachari V. Prog Mol Biol Transl Sci 174 331-373 (2020)
Articles - 1owt mentioned but not cited (6)
- A locking mechanism preventing radical damage in the absence of substrate, as revealed by the x-ray structure of lysine 5,6-aminomutase. Berkovitch F, Behshad E, Tang KH, Enns EA, Frey PA, Drennan CL. Proc Natl Acad Sci U S A 101 15870-15875 (2004)
- The structure of an archaeal homodimeric ligase which has RNA circularization activity. Brooks MA, Meslet-Cladiére L, Graille M, Kuhn J, Blondeau K, Myllykallio H, van Tilbeurgh H. Protein Sci 17 1336-1345 (2008)
- The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism. Spoerri L, Vella LJ, Pham CL, Barnham KJ, Cappai R. J Biol Chem 287 26840-26853 (2012)
- Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting. Schützmann MP, Hasecke F, Bachmann S, Zielinski M, Hänsch S, Schröder GF, Zempel H, Hoyer W. Nat Commun 12 4634 (2021)
- Crystal structure of calcium dodecin (Rv0379), from Mycobacterium tuberculosis with a unique calcium-binding site. Arockiasamy A, Aggarwal A, Savva CG, Holzenburg A, Sacchettini JC. Protein Sci 20 827-833 (2011)
- Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation. Huang Q, Lin J, Huang S, Shen J. Front Pharmacol 12 787816 (2021)
Reviews citing this publication (63)
- Neurodegenerative diseases and oxidative stress. Barnham KJ, Masters CL, Bush AI. Nat Rev Drug Discov 3 205-214 (2004)
- Molecular pathways to neurodegeneration. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Nat Med 10 Suppl S2-9 (2004)
- Oxidative stress and the pathogenesis of Alzheimer's disease. Zhao Y, Zhao B. Oxid Med Cell Longev 2013 316523 (2013)
- Copper in diseases and treatments, and copper-based anticancer strategies. Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Med Res Rev 30 708-749 (2010)
- Metals and amyloid-beta in Alzheimer's disease. Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX. Int J Exp Pathol 86 147-159 (2005)
- Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Greenough MA, Camakaris J, Bush AI. Neurochem Int 62 540-555 (2013)
- Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. Crouch PJ, Harding SM, White AR, Camakaris J, Bush AI, Masters CL. Int J Biochem Cell Biol 40 181-198 (2008)
- Metallostasis in Alzheimer's disease. Ayton S, Lei P, Bush AI. Free Radic Biol Med 62 76-89 (2013)
- Copper in the brain and Alzheimer's disease. Hung YH, Bush AI, Cherny RA. J Biol Inorg Chem 15 61-76 (2010)
- The role of metallobiology and amyloid-β peptides in Alzheimer's disease. Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA. J Neurochem 120 Suppl 1 149-166 (2012)
- Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. Masters CL, Cappai R, Barnham KJ, Villemagne VL. J Neurochem 97 1700-1725 (2006)
- Copper handling machinery of the brain. Lutsenko S, Bhattacharjee A, Hubbard AL. Metallomics 2 596-608 (2010)
- Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Gralle M, Ferreira ST. Prog Neurobiol 82 11-32 (2007)
- Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Rossi L, Mazzitelli S, Arciello M, Capo CR, Rotilio G. Neurochem Res 33 2390-2400 (2008)
- Structure and function of amyloid in Alzheimer's disease. Morgan C, Colombres M, Nuñez MT, Inestrosa NC. Prog Neurobiol 74 323-349 (2004)
- Amyloid accomplices and enforcers. Alexandrescu AT. Protein Sci 14 1-12 (2005)
- Copper and Alzheimer's disease. Donnelly PS, Xiao Z, Wedd AG. Curr Opin Chem Biol 11 128-133 (2007)
- Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals. Paterson BM, Donnelly PS. Chem Soc Rev 40 3005-3018 (2011)
- Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Rossi L, Lombardo MF, Ciriolo MR, Rotilio G. Neurochem Res 29 493-504 (2004)
- The physiological role of reversible methionine oxidation. Drazic A, Winter J. Biochim Biophys Acta 1844 1367-1382 (2014)
- Pathophysiology and clinical features of Wilson disease. Ferenci P. Metab Brain Dis 19 229-239 (2004)
- Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Singh N, Haldar S, Tripathi AK, Horback K, Wong J, Sharma D, Beserra A, Suda S, Anbalagan C, Dev S, Mukhopadhyay CK, Singh A. Antioxid Redox Signal 20 1324-1363 (2014)
- Copper deficiency and neurological disorders in man and animals. Zatta P, Frank A. Brain Res Rev 54 19-33 (2007)
- Wilson disease. Kitzberger R, Madl C, Ferenci P. Metab Brain Dis 20 295-302 (2005)
- Werner coordination chemistry and neurodegeneration. Telpoukhovskaia MA, Orvig C. Chem Soc Rev 42 1836-1846 (2013)
- Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures. Myhre O, Utkilen H, Duale N, Brunborg G, Hofer T. Oxid Med Cell Longev 2013 726954 (2013)
- Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease. Unzeta M, Esteban G, Bolea I, Fogel WA, Ramsay RR, Youdim MB, Tipton KF, Marco-Contelles J. Front Neurosci 10 205 (2016)
- The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease. Sulistio YA, Heese K. Mol Neurobiol 53 905-931 (2016)
- Toward structural elucidation of the gamma-secretase complex. Li H, Wolfe MS, Selkoe DJ. Structure 17 326-334 (2009)
- Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease. Cristóvão JS, Santos R, Gomes CM. Oxid Med Cell Longev 2016 9812178 (2016)
- Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease. Li Y, Jiao Q, Xu H, Du X, Shi L, Jia F, Jiang H. Front Mol Neurosci 10 339 (2017)
- Pharmacotherapeutic targets in Alzheimer's disease. Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PA. J Cell Mol Med 13 61-86 (2009)
- Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD). Zhao Y, Bhattacharjee S, Jones BM, Hill JM, Clement C, Sambamurti K, Dua P, Lukiw WJ. Mol Neurobiol 52 533-544 (2015)
- Mouse models of Alzheimer's disease: the long and filamentous road. Phinney AL, Horne P, Yang J, Janus C, Bergeron C, Westaway D. Neurol Res 25 590-600 (2003)
- Metal homeostasis in Alzheimer's disease. White AR, Barnham KJ, Bush AI. Expert Rev Neurother 6 711-722 (2006)
- ER chaperone-metal interactions: links to protein folding disorders. Tiffany-Castiglioni E, Qian Y. Neurotoxicology 33 545-557 (2012)
- Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology. Wong BX, Hung YH, Bush AI, Duce JA. Front Aging Neurosci 6 91 (2014)
- The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease. Drew SC. Front Neurosci 11 317 (2017)
- Alpha-synuclein: relating metals to structure, function and inhibition. McDowall JS, Brown DR. Metallomics 8 385-397 (2016)
- Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis? Hofer T, Perry G. J Trace Elem Med Biol 38 1-9 (2016)
- Amyloid precursor protein and BACE function as oligomers. Multhaup G. Neurodegener Dis 3 270-274 (2006)
- Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer's and Parkinson's Disease: Insight into the Role of Nrf-2 and A2AR Signaling. Ikram M, Park TJ, Ali T, Kim MO. Antioxidants (Basel) 9 E902 (2020)
- Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease. Bica L, Crouch PJ, Cappai R, White AR. Mol Biosyst 5 134-142 (2009)
- Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments. Wild K, August A, Pietrzik CU, Kins S. Front Mol Neurosci 10 21 (2017)
- Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding. Scharfenberg F, Armbrust F, Marengo L, Pietrzik C, Becker-Pauly C. Cell Mol Life Sci 76 3193-3206 (2019)
- Role of metal ions in the cognitive decline of Down syndrome. Malakooti N, Pritchard MA, Adlard PA, Finkelstein DI. Front Aging Neurosci 6 136 (2014)
- Interrelation of Ca2+ and PE_PGRS proteins during Mycobacterium tuberculosis pathogenesis. Meena LS. J Biosci 44 (2019)
- Amyloid scaffolds as alternative chlorosomes. Rengifo RF, Li NX, Sementilli A, Lynn DG. Org Biomol Chem 15 7063-7071 (2017)
- Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease. Lakey-Beitia J, Burillo AM, La Penna G, Hegde ML, Rao KS. J Alzheimers Dis 82 S335-S357 (2021)
- Applications of electron paramagnetic resonance to studies of neurological disease. Boas JF, Drew SC, Curtain CC. Eur Biophys J 37 281-294 (2008)
- Amyloidogenicity at a Distance: How Distal Protein Regions Modulate Aggregation in Disease. Lucato CM, Lupton CJ, Halls ML, Ellisdon AM. J Mol Biol 429 1289-1304 (2017)
- Membrane-targeted strategies for modulating APP and Abeta-mediated toxicity. Price KA, Crouch PJ, Donnelly PS, Masters CL, White AR, Curtain CC. J Cell Mol Med 13 249-261 (2009)
- Redox signaling and metabolism in Alzheimer's disease. Holubiec MI, Gellert M, Hanschmann EM. Front Aging Neurosci 14 1003721 (2022)
- Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer's Disease Development. Urban AS, Pavlov KV, Kamynina AV, Okhrimenko IS, Arseniev AS, Bocharov EV. Molecules 26 (2021)
- Water Quality and Brain Function. Bondy SC, Campbell A. Int J Environ Res Public Health 15 (2017)
- High resolution approaches for the identification of amyloid fragments in brain. Ross JA, Mathews PM, Van Bockstaele EJ. J Neurosci Methods 319 7-15 (2019)
- Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine. Botchway BOA, Liu X, Zhou Y, Fang M. J Transl Med 21 351 (2023)
- Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives. Bhole RP, Chikhale RV, Rathi KM. IBRO Neurosci Rep 16 8-42 (2024)
- Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases. Korczowska-Łącka I, Słowikowski B, Piekut T, Hurła M, Banaszek N, Szymanowicz O, Jagodziński PP, Kozubski W, Permoda-Pachuta A, Dorszewska J. Antioxidants (Basel) 12 1811 (2023)
- Exposure of metal toxicity in Alzheimer's disease: An extensive review. Islam F, Shohag S, Akhter S, Islam MR, Sultana S, Mitra S, Chandran D, Khandaker MU, Ashraf GM, Idris AM, Emran TB, Cavalu S. Front Pharmacol 13 903099 (2022)
- N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases. Martinez-Banaclocha M. Antioxidants (Basel) 11 416 (2022)
- Structural biology of cell surface receptors implicated in Alzheimer's disease. Hermans SJ, Nero TL, Morton CJ, Gooi JH, Crespi GAN, Hancock NC, Gao C, Ishii K, Markulić J, Parker MW. Biophys Rev 14 233-255 (2022)
- The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis. Majerníková N, den Dunnen WFA, Dolga AM. Front Aging Neurosci 13 745046 (2021)
Articles citing this publication (73)
- Role of oxidative stress in Alzheimer's disease. Huang WJ, Zhang X, Chen WW. Biomed Rep 4 519-522 (2016)
- Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Bayer TA, Schäfer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schüssel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G. Proc Natl Acad Sci U S A 100 14187-14192 (2003)
- Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, Zweckstetter M, Griesinger C, Jovin TM, Fernández CO. Proc Natl Acad Sci U S A 102 4294-4299 (2005)
- In vivo reduction of amyloid-beta by a mutant copper transporter. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang J, Sekoulidis J, Coomaraswamy J, Chishti MA, Cox DW, Mathews PM, Nixon RA, Carlson GA, St George-Hyslop P, Westaway D. Proc Natl Acad Sci U S A 100 14193-14198 (2003)
- Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. Nelson TJ, Alkon DL. J Biol Chem 280 7377-7387 (2005)
- The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Wang Y, Ha Y. Mol Cell 15 343-353 (2004)
- Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF. Urology 64 399-404 (2004)
- Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, Camakaris J. J Biol Chem 279 20378-20386 (2004)
- Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. Kitazawa M, Cheng D, Laferla FM. J Neurochem 108 1550-1560 (2009)
- Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts. Bhattacharyya R, Barren C, Kovacs DM. J Neurosci 33 11169-11183 (2013)
- Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect beta-secretase cleavage of APP. Kaden D, Munter LM, Joshi M, Treiber C, Weise C, Bethge T, Voigt P, Schaefer M, Beyermann M, Reif B, Multhaup G. J Biol Chem 283 7271-7279 (2008)
- Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution. Ciccotosto GD, Tew D, Curtain CC, Smith D, Carrington D, Masters CL, Bush AI, Cherny RA, Cappai R, Barnham KJ. J Biol Chem 279 42528-42534 (2004)
- Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease. Treiber C, Simons A, Strauss M, Hafner M, Cappai R, Bayer TA, Multhaup G. J Biol Chem 279 51958-51964 (2004)
- Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation. Leong SL, Pham CL, Galatis D, Fodero-Tavoletti MT, Perez K, Hill AF, Masters CL, Ali FE, Barnham KJ, Cappai R. Free Radic Biol Med 46 1328-1337 (2009)
- Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Dahms SO, Hoefgen S, Roeser D, Schlott B, Gührs KH, Than ME. Proc Natl Acad Sci U S A 107 5381-5386 (2010)
- Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions. Kong GK, Adams JJ, Harris HH, Boas JF, Curtain CC, Galatis D, Masters CL, Barnham KJ, McKinstry WJ, Cappai R, Parker MW. J Mol Biol 367 148-161 (2007)
- Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. Kessler H, Bayer TA, Bach D, Schneider-Axmann T, Supprian T, Herrmann W, Haber M, Multhaup G, Falkai P, Pajonk FG. J Neural Transm (Vienna) 115 1181-1187 (2008)
- Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein. Gralle M, Oliveira CL, Guerreiro LH, McKinstry WJ, Galatis D, Masters CL, Cappai R, Parker MW, Ramos CH, Torriani I, Ferreira ST. J Mol Biol 357 493-508 (2006)
- Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. Kessler H, Pajonk FG, Meisser P, Schneider-Axmann T, Hoffmann KH, Supprian T, Herrmann W, Obeid R, Multhaup G, Falkai P, Bayer TA. J Neural Transm (Vienna) 113 1763-1769 (2006)
- Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Lu J, Wu DM, Zheng YL, Sun DX, Hu B, Shan Q, Zhang ZF, Fan SH. Brain Behav Immun 23 193-203 (2009)
- 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. Squitti R, Ventriglia M, Barbati G, Cassetta E, Ferreri F, Dal Forno G, Ramires S, Zappasodi F, Rossini PM. J Neural Transm (Vienna) 114 1589-1594 (2007)
- Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis. Lu J, Zheng YL, Wu DM, Sun DX, Shan Q, Fan SH. FEBS Lett 580 6730-6740 (2006)
- Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. Caragounis A, Du T, Filiz G, Laughton KM, Volitakis I, Sharples RA, Cherny RA, Masters CL, Drew SC, Hill AF, Li QX, Crouch PJ, Barnham KJ, White AR. Biochem J 407 435-450 (2007)
- The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo. Cappai R, Cheng F, Ciccotosto GD, Needham BE, Masters CL, Multhaup G, Fransson LA, Mani K. J Biol Chem 280 13913-13920 (2005)
- Toxicity of Alzheimer's disease-associated Aβ peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Hua H, Münter L, Harmeier A, Georgiev O, Multhaup G, Schaffner W. Biol Chem 392 919-926 (2011)
- Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid. Nelson TJ, Alkon DL. J Biol Chem 282 31238-31249 (2007)
- Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease. Squitti R, Quattrocchi CC, Salustri C, Rossini PM. Prion 2 23-27 (2008)
- EPR-based approach for the localization of paramagnetic metal ions in biomolecules. Abdullin D, Florin N, Hagelueken G, Schiemann O. Angew Chem Int Ed Engl 54 1827-1831 (2015)
- Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. Kessler H, Pajonk FG, Bach D, Schneider-Axmann T, Falkai P, Herrmann W, Multhaup G, Wiltfang J, Schäfer S, Wirths O, Bayer TA. J Neural Transm (Vienna) 115 1651-1659 (2008)
- The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals. Donnelly PS. Dalton Trans 40 999-1010 (2011)
- Copper enhances APP dimerization and promotes Aβ production. Noda Y, Asada M, Kubota M, Maesako M, Watanabe K, Uemura M, Kihara T, Shimohama S, Takahashi R, Kinoshita A, Uemura K. Neurosci Lett 547 10-15 (2013)
- Identification of a novel high affinity copper binding site in the APP(145-155) fragment of amyloid precursor protein. Valensin D, Mancini FM, Łuczkowski M, Janicka A, Wisniewska K, Gaggelli E, Valensin G, Łankiewicz L, Kozlowski H. Dalton Trans 16-22 (2004)
- NMR studies on Cu(II)-peptide complexes: exchange kinetics and determination of structures in solution. Gaggelli E, Kozlowski H, Valensin D, Valensin G. Mol Biosyst 1 79-84 (2005)
- Analysis of the overall structure of the multi-domain amyloid precursor protein (APP). Coburger I, Dahms SO, Roeser D, Gührs KH, Hortschansky P, Than ME. PLoS One 8 e81926 (2013)
- Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry. Haeffner F, Smith DG, Barnham KJ, Bush AI. J Inorg Biochem 99 2403-2422 (2005)
- N-cadherin enhances APP dimerization at the extracellular domain and modulates Aβ production. Asada-Utsugi M, Uemura K, Noda Y, Kuzuya A, Maesako M, Ando K, Kubota M, Watanabe K, Takahashi M, Kihara T, Shimohama S, Takahashi R, Berezovska O, Kinoshita A. J Neurochem 119 354-363 (2011)
- In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Green DE, Bowen ML, Scott LE, Storr T, Merkel M, Böhmerle K, Thompson KH, Patrick BO, Schugar HJ, Orvig C. Dalton Trans 39 1604-1615 (2010)
- An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease. Zappasodi F, Salustri C, Babiloni C, Cassetta E, Del Percio C, Ercolani M, Rossini PM, Squitti R. Brain Res 1215 183-189 (2008)
- Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis. Needham BE, Ciccotosto GD, Cappai R. Metallomics 6 598-603 (2014)
- Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments. Vella LJ, Cappai R. FASEB J 26 2930-2940 (2012)
- Peculiarities of copper binding to alpha-synuclein. Ahmad A, Burns CS, Fink AL, Uversky VN. J Biomol Struct Dyn 29 825-842 (2012)
- Perturbations of the straight transmembrane α-helical structure of the amyloid precursor protein affect its processing by γ-secretase. Lemmin T, Dimitrov M, Fraering PC, Dal Peraro M. J Biol Chem 289 6763-6774 (2014)
- Mouse brain synaptosomes accumulate copper-67 efficiently by two distinct processes independent of cellular prion protein. Giese A, Buchholz M, Herms J, Kretzschmar HA. J Mol Neurosci 27 347-354 (2005)
- Structural characterization of the E2 domain of APL-1, a Caenorhabditis elegans homolog of human amyloid precursor protein, and its heparin binding site. Hoopes JT, Liu X, Xu X, Demeler B, Folta-Stogniew E, Li C, Ha Y. J Biol Chem 285 2165-2173 (2010)
- Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse? Schmechel DE. Neurotoxicology 28 899-914 (2007)
- Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion? Mantri Y, Fioroni M, Baik MH. J Biol Inorg Chem 13 1197-1204 (2008)
- Copper(II) complexes of hybrid hydroxyquinoline-thiosemicarbazone ligands: GSK3β inhibition due to intracellular delivery of copper. Hickey JL, Crouch PJ, Mey S, Caragounis A, White JM, White AR, Donnelly PS. Dalton Trans 40 1338-1347 (2011)
- Neuroprotective Role of a Novel Copper Chelator against Aβ 42 Induced Neurotoxicity. Singh SK, Sinha P, Mishra L, Srikrishna S. Int J Alzheimers Dis 2013 567128 (2013)
- Re-partitioning of Cu and Zn isotopes by modified protein expression. Büchl A, Hawkesworth CJ, Ragnarsdottir KV, Brown DR. Geochem Trans 9 11 (2008)
- Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients. Squitti R, Quattrocchi CC, Forno GD, Antuono P, Wekstein DR, Capo CR, Salustri C, Rossini PM. Biomark Insights 1 205-213 (2007)
- The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines. Hicks DA, Makova NZ, Gough M, Parkin ET, Nalivaeva NN, Turner AJ. J Biol Chem 288 26039-26051 (2013)
- The amyloid precursor protein shows a pH-dependent conformational switch in its E1 domain. Hoefgen S, Dahms SO, Oertwig K, Than ME. J Mol Biol 427 433-442 (2015)
- The effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused rats. Mao X, Ye J, Zhou S, Pi R, Dou J, Zang L, Chen X, Chao X, Li W, Liu M, Liu P. Neurosci Lett 518 14-18 (2012)
- Copper reduction and dioxygen activation in Cu-amyloid beta peptide complexes: insight from molecular modelling. Arrigoni F, Prosdocimi T, Mollica L, De Gioia L, Zampella G, Bertini L. Metallomics 10 1618-1630 (2018)
- Quantification of copper binding to amyloid precursor protein domain 2 and its Caenorhabditis elegans ortholog. Implications for biological function. Leong SL, Young TR, Barnham KJ, Wedd AG, Hinds MG, Xiao Z, Cappai R. Metallomics 6 105-116 (2014)
- Amyloid β-peptide and Alzheimer's disease. Allsop D, Mayes J. Essays Biochem 56 99-110 (2014)
- Quantitation and localization of intracellular redox active metals by X-ray fluorescence microscopy in cortical neurons derived from APP and APLP2 knockout tissue. Ciccotosto GD, James SA, Altissimo M, Paterson D, Vogt S, Lai B, de Jonge MD, Howard DL, Bush AI, Cappai R. Metallomics 6 1894-1904 (2014)
- On the metal ion (Zn(2+), Cu(2+)) coordination with beta-amyloid peptide: DFT computational study. Marino T, Russo N, Toscano M, Pavelka M. Interdiscip Sci 2 57-69 (2010)
- Peculiar reactivity of a di-imine copper(II) complex regarding its binding to albumin protein. Silveira VC, Abbott MP, Cavicchioli M, Gonçalves MB, Petrilli HM, de Rezende L, Amaral AT, Fonseca DE, Caramori GF, Ferreira AM. Dalton Trans 42 6386-6396 (2013)
- Serum and brain natural copper stable isotopes in a mouse model of Alzheimer's disease. Moynier F, Creech J, Dallas J, Le Borgne M. Sci Rep 9 11894 (2019)
- Crystallization and preliminary crystallographic studies of the copper-binding domain of the amyloid precursor protein of Alzheimer's disease. Kong GK, Galatis D, Barnham KJ, Polekhina G, Adams JJ, Masters CL, Cappai R, Parker MW, McKinstry WJ. Acta Crystallogr Sect F Struct Biol Cryst Commun 61 93-95 (2005)
- Iron regulatory protein 2 is involved in brain copper homeostasis. Mueller C, Magaki S, Schrag M, Ghosh MC, Kirsch WM. J Alzheimers Dis 18 201-210 (2009)
- Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques. Zhu X, Victor TW, Ambi A, Sullivan JK, Hatfield J, Xu F, Miller LM, Van Nostrand WE. Metallomics 12 539-546 (2020)
- Dual role of Cu²⁺ ions on the aggregation and degradation of soluble Aβ oligomers and protofibrils investigated by fluorescence spectroscopy and AFM. García S, Cuscó C, Brissos RF, Torrents E, Caubet A, Gamez P. J Inorg Biochem 116 26-36 (2012)
- DBGSA: a novel method of distance-based gene set analysis. Li J, Wang L, Xu L, Zhang R, Huang M, Wang K, Xu J, Lv H, Shang Z, Zhang M, Jiang Y, Guo M, Li X. J Hum Genet 57 642-653 (2012)
- Re-evaluation of the existing health-based guidance values for copper and exposure assessment from all sources. EFSA Scientific Committee, More SJ, Bampidis V, Benford D, Bragard C, Halldorsson TI, Hernández-Jerez AF, Bennekou SH, Koutsoumanis K, Lambré C, Machera K, Mullins E, Nielsen SS, Schlatter JR, Schrenk D, Turck D, Younes M, Boon P, Ferns GA, Lindtner O, Smolders E, Wilks M, Bastaki M, de Sesmaisons-Lecarré A, Ferreira L, Greco L, Kass GEN, Riolo F, Leblanc JC. EFSA J 21 e07728 (2023)
- The Amyloid Precursor Protein of Alzheimer's Disease Clusters at the Organelle/Microtubule Interface on Organelles that Bind Microtubules in an ATP Dependent Manner. Stevenson JW, Conaty EA, Walsh RB, Poidomani PJ, Samoriski CM, Scollins BJ, DeGiorgis JA. PLoS One 11 e0147808 (2016)
- Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease. Dewji NN, Singer SJ, Masliah E, Rockenstein E, Kim M, Harber M, Horwood T. PLoS One 10 e0122451 (2015)
- Low concentrations of copper in drinking water increase AP-1 binding in the brain. Lung S, Li H, Bondy SC, Campbell A. Toxicol Ind Health 31 1178-1184 (2015)
- Comparing mRNA expression and protein abundance in MDR Mycobacterium tuberculosis: Novel protein candidates, Rv0443, Rv0379 and Rv0147 as TB potential diagnostic or therapeutic targets. Hadizadeh Tasbiti A, Yari S, Siadat SD, Karimipoor M, Badmasti F, Masoumi M, Abdolrahimi F, Khanipour S, Hassanzadeh SM, Ghalami Nobar M, Yari F. Biotechnol Rep (Amst) 30 e00641 (2021)
- Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer's Disease. Singh HN, Swarup V, Dubey NK, Jha NK, Singh AK, Lo WC, Kumar S. Biomedicines 10 611 (2022)
- MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. Dhana K, James BD, Agarwal P, Aggarwal NT, Cherian LJ, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. J Alzheimers Dis 83 683-692 (2021)
- ZOMEC via the p-Akt/Nrf2 Pathway Restored PTZ-Induced Oxidative Stress-Mediated Memory Dysfunction in Mouse Model. Jahan R, Yousaf M, Khan H, Bibi N, Ijaz M, Rehan T, Shah SA. Biomed Res Int 2022 8902262 (2022)